Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
- 27 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 7 (2), 676-682
- https://doi.org/10.1007/s12072-012-9392-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virusThe Esophagus, 2009
- Evaluation of Model for End Stage Liver Disease (MELD)‐based systems as prognostic index for hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2009
- The Utility of Lens Culinaris Agglutinin-Reactive α-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: Evaluation in a United States Referral PopulationClinical Gastroenterology and Hepatology, 2007
- Management of hepatocellular carcinomaJournal of Hepatology, 2005
- Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patientsJournal of Hepatology, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaJournal of Hepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinomaCancer, 1992
- A clinical and pathological study of diffuse type hepatocellular carcinomaLiver International, 1981